• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子相互作用场(MIFs)预测抗肿瘤 Pt(II) 配合物的亲脂性和 ADME 特征。

Molecular interaction fields (MIFs) to predict lipophilicity and ADME profile of antitumor Pt(II) complexes.

机构信息

CASSMedChem Research Group, DSTF at the Centre for Innovation, Università di Torino, Via Quarello 11, 10135, Torino, Italy.

出版信息

Pharm Res. 2011 Mar;28(3):640-6. doi: 10.1007/s11095-010-0317-1. Epub 2010 Nov 17.

DOI:10.1007/s11095-010-0317-1
PMID:21082220
Abstract

PURPOSE

To describe a computational tool to calculate molecular descriptors of potential application in ADME virtual screening of antitumor Pt(II) drug candidates.

METHODS

The multistep computational procedure consists in (a) building and optimization (PM3) of the 3D structures of the investigated complexes, (b) parametrization of Pt(II) and its implementation in GRID, (c) GRID calculations and extraction of the information content with VolSurf and BIOCUBE4mf, and (d) PLS analysis to look for the correlation between experimental data and the molecular descriptors.

RESULTS

The following results were obtained: (a) the calibration of the GRID force field to take into account the platinum di-cation, (b) solid PLS models between log k30 and log kw with VolSurf descriptors which highlight the main structural differences between the two chromatographic parameters, (c) the prediction of virtual (of each conformer) log k30 and log kw, and (d) the identification of the main descriptors governing VD(ss) of drugs in clinical use.

CONCLUSION

The study suggests a strategy to identify good Pt(II) complexes prior to their synthesis to eliminate as soon as possible drug candidates with unfavorable PK profile.

摘要

目的

描述一种计算工具,用于计算在 ADME 虚拟筛选抗肿瘤 Pt(II)药物候选物中的潜在应用的分子描述符。

方法

该多步计算程序包括(a) 研究复合物的 3D 结构的构建和优化(PM3),(b) Pt(II)的参数化及其在 GRID 中的实现,(c) GRID 计算和 VolSurf 和 BIOCUBE4mf 中的信息内容提取,以及(d) PLS 分析以寻找实验数据和分子描述符之间的相关性。

结果

得到了以下结果:(a) 对 GRID 力场进行校准以考虑铂二价阳离子,(b) 在 VolSurf 描述符之间具有固体 PLS 模型,这些描述符突出了两个色谱参数之间的主要结构差异,(c) 虚拟(每个构象)log k30 和 log kw 的预测,以及(d) 识别临床使用药物 VD(ss)的主要描述符。

结论

该研究提出了一种在合成之前识别良好的 Pt(II) 配合物的策略,以尽快消除具有不利 PK 特征的药物候选物。

相似文献

1
Molecular interaction fields (MIFs) to predict lipophilicity and ADME profile of antitumor Pt(II) complexes.分子相互作用场(MIFs)预测抗肿瘤 Pt(II) 配合物的亲脂性和 ADME 特征。
Pharm Res. 2011 Mar;28(3):640-6. doi: 10.1007/s11095-010-0317-1. Epub 2010 Nov 17.
2
Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.分子相互作用场与基于量子力学的描述符在铂(IV)配合物脂溶性建模中的比较。
Dalton Trans. 2013 Mar 14;42(10):3482-9. doi: 10.1039/c2dt32360e. Epub 2012 Dec 21.
3
Modelling steric effects in DNA-binding platinum(II)-am(m)ine complexes.模拟DNA结合铂(II)-胺配合物中的空间效应。
J Comput Aided Mol Des. 1996 Dec;10(6):589-606. doi: 10.1007/BF00134182.
4
NMR spectroscopy of anticancer platinum drugs.抗癌铂类药物的核磁共振光谱分析
Anticancer Agents Med Chem. 2007 Jan;7(1):35-54. doi: 10.2174/187152007779313982.
5
Structural studies of interactions between anticancer platinum drugs and DNA.抗癌铂类药物与DNA相互作用的结构研究
Prog Biophys Mol Biol. 1996;66(1):81-111. doi: 10.1016/s0079-6107(96)00017-x.
6
Pt NMR parameters as strong descriptors in one-parameter QSAR models for platinum-based antitumor compounds.铂核磁共振参数作为基于铂的抗肿瘤化合物单参数定量构效关系模型中的强描述符。
Magn Reson Chem. 2017 Jul;55(7):662-669. doi: 10.1002/mrc.4570. Epub 2017 Jan 24.
7
Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.硅铂烷及由β-硅烷基胺衍生的相关铂(II)和铂(IV)配合物的合成、抗肿瘤活性及化学性质
J Med Chem. 1995 Sep 15;38(19):3789-97. doi: 10.1021/jm00019a008.
8
Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods.铂(II)配合物亲脂性的计算:几种方法的实验比较
J Inorg Biochem. 2008 Jul;102(7):1424-37. doi: 10.1016/j.jinorgbio.2007.12.029. Epub 2008 Jan 8.
9
Bis[platinum(II)] and bis[platinum(IV)] complexes with optically active bis(vicinal-1,2-diamines) and their interaction with DNA.具有光学活性双(邻位-1,2-二胺)的双[铂(II)]和双[铂(IV)]配合物及其与DNA的相互作用。
J Inorg Biochem. 1999 Jul 15;75(4):269-79. doi: 10.1016/s0162-0134(99)00099-9.
10
Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.人类癌细胞系对铂(II)与铂(IV)抗癌药物的化学敏感性和耐药性特征分析。
Anticancer Drugs. 2009 Aug;20(7):559-72. doi: 10.1097/CAD.0b013e32832d513b.

本文引用的文献

1
The drug targeting and delivery approach applied to pt-antitumour complexes. A coordination point of view.靶向和递药方法在铂-抗肿瘤配合物中的应用。配位观点。
Curr Med Chem. 2009;16(34):4544-80. doi: 10.2174/092986709789760661.
2
Partition coefficient and molecular flexibility: the concept of lipophilicity space.分配系数与分子柔性:亲脂性空间的概念
Chem Biodivers. 2009 Aug;6(8):1152-69. doi: 10.1002/cbdv.200900072.
3
The relevance of polar surface area (PSA) in rationalizing biological properties of several cis-diamminemalonatoplatinum(II) derivatives.
极表面积(PSA)在阐释几种顺式二氨丙二酸铂(II)衍生物生物学性质方面的相关性。
ChemMedChem. 2009 Oct;4(10):1677-85. doi: 10.1002/cmdc.200900224.
4
In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set.使用线性和非线性模型对669个化合物数据集进行人体分布容积的计算机模拟预测。
J Med Chem. 2009 Jul 23;52(14):4488-95. doi: 10.1021/jm9004658.
5
How to extend the use of grid-based interaction energy maps from chemistry to biotopics.如何将基于网格的相互作用能图的应用从化学领域扩展到生物主题。
ChemMedChem. 2009 Jan;4(1):29-36. doi: 10.1002/cmdc.200800259.
6
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.对670种药物化合物的人体静脉药代动力学参数数据库进行趋势分析。
Drug Metab Dispos. 2008 Jul;36(7):1385-405. doi: 10.1124/dmd.108.020479. Epub 2008 Apr 21.
7
Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods.铂(II)配合物亲脂性的计算:几种方法的实验比较
J Inorg Biochem. 2008 Jul;102(7):1424-37. doi: 10.1016/j.jinorgbio.2007.12.029. Epub 2008 Jan 8.
8
The resurgence of platinum-based cancer chemotherapy.基于铂的癌症化疗的复兴。
Nat Rev Cancer. 2007 Aug;7(8):573-84. doi: 10.1038/nrc2167. Epub 2007 Jul 12.
9
The RP-HPLC measurement and QSPR analysis of logP(o/w) values of several Pt(II) complexes.几种Pt(II)配合物的logP(o/w)值的反相高效液相色谱测定及定量构效关系分析
J Inorg Biochem. 2006 Jul;100(7):1199-207. doi: 10.1016/j.jinorgbio.2006.01.035.
10
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).计算烷烃/水体系中的虚拟 log P(log P(N)(alk))及其衍生参数 Δlog P(N)(oct-alk) 和 log D(pH)(alk)。
J Med Chem. 2005 May 5;48(9):3269-79. doi: 10.1021/jm048980b.